Comment of the effectiveness of targeted prodrugs such as Xeloda for specific cancers such as liver tumors, as well as their effectiveness as a broad "cure for cancer". Compare the "targeted" pro-drug strategy of Xeloda with the "bioavailability" prodrug strategy of Lexiva.